| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
8; discussion 79 |
| issn |
0920-1211 |
| issueIdentifier |
1-3 |
| pageRange |
75-8; discussion 79 |
| publicationName |
Epilepsy Research |
| startingPage |
75 |
| bibliographicCitation |
Kälviäinen R. Monotherapy trial design: conversion versus de novo. Epilepsy Res. 2001 May;45(1-3):75–8; discussion 79. doi: 10.1016/s0920-1211(01)00222-4. PMID: 11461801. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3b1db3596bf3f69d246ee208fbe8d15 |
| date |
200105 |
| identifier |
https://doi.org/10.1016/s0920-1211%2801%2900222-4
https://pubmed.ncbi.nlm.nih.gov/11461801 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0920-1211
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Monotherapy trial design: conversion versus de novo |
| discusses |
http://id.nlm.nih.gov/mesh/M0001382 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D004827Q000188
http://id.nlm.nih.gov/mesh/D000927Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D002986
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D012107
http://id.nlm.nih.gov/mesh/D004827Q000175
http://id.nlm.nih.gov/mesh/D000927Q000009 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16760703
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3549980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2554
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617 |